|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
CA2157584C
(en)
*
|
1993-03-03 |
1999-05-04 |
Paul Mulhauser |
Dry powder medicament inhalator
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
ES2216418T3
(es)
|
1995-12-07 |
2004-10-16 |
Jago Research Ag |
Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
BR0108730A
(pt)
|
2000-02-28 |
2002-11-05 |
Vectura Ltd |
Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
CA2477604A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
WO2006084033A1
(en)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US8653028B2
(en)
*
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
|
CA2620123C
(en)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315527S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
DK2155228T3
(da)
|
2007-01-10 |
2014-07-07 |
Purdue Research Foundation |
Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
|
|
JP5703466B2
(ja)
*
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
キナーゼ阻害薬およびその使用
|
|
CN101980738A
(zh)
|
2008-02-07 |
2011-02-23 |
华盛顿大学 |
圆周气雾设备
|
|
JP5622720B2
(ja)
*
|
2008-05-21 |
2014-11-12 |
ニューロテスインコーポレイテッド |
神経原繊維変化に関連する進行性認知障害の治療方法
|
|
SG10201507036TA
(en)
*
|
2008-06-13 |
2015-10-29 |
Mannkind Corp |
A dry powder inhaler and system for drug delivery
|
|
KR20170001756A
(ko)
*
|
2008-10-20 |
2017-01-04 |
모레 매트릭스 인코포레이티드 |
유착 치료 또는 예방용 폴리펩티드
|
|
CA2742600A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
|
AU2009324661A1
(en)
*
|
2008-12-10 |
2011-07-07 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
|
SG10201500620PA
(en)
|
2009-07-24 |
2015-03-30 |
Amazentis Sa |
Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
|
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
RU2612506C2
(ru)
|
2011-03-03 |
2017-03-09 |
Импел Ньюрофарма Инк. |
Устройство для назальной доставки лекарственных средств
|
|
SG194135A1
(en)
|
2011-04-12 |
2013-11-29 |
Matrix Inc Moerae |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
CN103619340B
(zh)
|
2011-04-25 |
2016-08-17 |
康奈尔大学 |
尿苷和脱氧尿苷在治疗叶酸应答性病变中的用途
|
|
WO2012154859A1
(en)
|
2011-05-09 |
2012-11-15 |
Impel Neuropharma Inc. |
Nozzles for nasal drug delivery
|
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
|
PL2892524T3
(pl)
|
2012-09-04 |
2021-10-25 |
Eleison Pharmaceuticals, Llc |
Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
|
|
EP2991713B1
(en)
|
2013-04-28 |
2019-06-19 |
Impel Neuropharma Inc. |
Medical unit dose container
|
|
US10207065B2
(en)
|
2013-07-12 |
2019-02-19 |
John H. Silva |
Mouthpiece for inhalers
|
|
KR102300576B1
(ko)
|
2013-09-10 |
2021-09-08 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
절단된 선종성 결장 폴립증 (ａｐｃ) 단백질을 타겟화하는 치료제
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
KR20170083063A
(ko)
|
2014-11-17 |
2017-07-17 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
|
|
EP3229831B1
(en)
|
2014-12-10 |
2020-03-11 |
Hyperstem SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
|
|
US10087225B2
(en)
|
2015-01-08 |
2018-10-02 |
Moerae Matrix, Inc. |
Formulation of MK2 inhibitor peptides
|
|
RU2017135072A
(ru)
|
2015-03-12 |
2019-04-10 |
Мори Матрикс, Инк. |
Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
|
|
CA2987071A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
|
WO2017007634A1
(en)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
|
DK3322417T3
(da)
|
2015-07-15 |
2023-10-30 |
Univ Texas |
Målretning af emopamil-bindingsprotein (EBP) med små molekyler, der inducerer et unormalt feedbackrespons ved sænkning af endogen cholesterolsyntese
|
|
NZ741171A
(en)
|
2015-09-10 |
2022-01-28 |
Impel Neuropharma Inc |
In-line nasal delivery device
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
US10328216B2
(en)
|
2016-01-20 |
2019-06-25 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation
|
|
EP3713628A4
(en)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
INTRA-NASAL DEVICE WITH DIVER TUBE
|
|
CA3081680A1
(en)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Intranasal device with inlet interface
|
|
JP7317020B2
(ja)
|
2018-01-05 |
2023-07-28 |
インペル ファーマシューティカルズ インコーポレイテッド |
精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
|
|
US11278492B2
(en)
|
2018-01-05 |
2022-03-22 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
JP2021532098A
(ja)
|
2018-07-19 |
2021-11-25 |
インペル ニューロファーマ インコーポレイテッド |
パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達
|
|
AU2019418744B2
(en)
|
2019-01-03 |
2023-08-03 |
Impel Pharmaceuticals Inc. |
Nasal drug delivery device
|
|
BR112021023049A8
(pt)
|
2019-05-17 |
2022-10-18 |
Impel Neuropharma Inc |
Dispositivo de dispensação nasal de uso único
|